Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of Serono Symposia International Foundation. All presentations solely represent the independent views of the presenters/authors.
Raúl Arcega: Declared no potential conflict of interest
Jorge Barahona Strauch: Declared receipt of honoraria or consultation fees from Biogen, Bayer, Serono, Teva
Giancarlo Comi: Declared receipt of honoraria or consultation fees from Teva Pharmaceutical Ind. Ltd., Sanofi-Aventis, Serono Symposia Int´l Foundation, Biogen-Dompe, Bayer-Schering, Merck Serono Int.
Teresa Corona: Declared no potential conflict of interest.
Edgardo Cristiano: Declared no potential conflict of interest.
Carlos Cuevas: Declared receipt of grants and contracts from: Bayer-Schering. Declared receipt of honoraria or consultant fees from Teva, Bayer-Schering, Biogen Idec. Member of Advisory Board of Teva Neurosciences Mexico.
Oscar Fernandez Fernández: Declared no potential conflict of interest.
José Flores Rivera: Declared no potential conflict of interest.
Mark S. Freedman: Declared receipt of grants and contract from Bayer Healthcare. Declared receipt of honoraria and consultation fees from: Biogen ldec, BayerHealthcare, EMD Serono, Teva, Novartis, Sanofi-Aventis. Member of Advisory Board, Board of Directors of other similar from Bayer-Schering Pharma, Biogen ldec, Merck Serono, Novartis, Sanofi-Aventis
Miguel Angel Macías: Declared receipt of grants and contract from Merck Serono. Member of Merck Serono Advisory Board.
Liliana Patrucco: Declared no potential conflict of interest.
Víctor M. Rivera: Declared receipt of grants and contract from Biogen ldec, Teva, National Ms Society. Declared receipt of honoraria and consultation fees from Biogen ldec and Novartis. Member of National MS Society and Consortium of MS Centers. Declared to have participation in the following companies sponsored speakers bureau: Bayer, Biogen ldec, MerckSerono, Teva, Stendhal Neuroscience. Declared otherwise benefit from a relationship with a commercial enterprise: Consultant from National MS Society and Consortium of MS Centers
Christine Stadelmann-Nessler: Declared no potential conflict of interest.
Silvia Tenembaum: Declared that her presentation will include discussion of some off-labeled or otherwise non-approved used of some products. She will discuss current experience on the off-labeled use of DMD in children with multiple sclerosis, based on recently published studies and her personal experience.
Soniza Vieira Alves León: Declared no potential conflict of interest.
